PrIME is a cancer molecular test that incorporates a 500+ tumor-related multi-gene panel associated with targeted therapies.
Furthermore, it includes three major biomarkers (PD-L1, MSI and TMB) related to the response to immunotherapy.
The information from the PrIME test helps the doctor with the patient’s cancer prognosis and response to treatment, including immunotherapy.
It requires a paraffin block with the tumor tissue and it takes about 15 working days to receive the results.
For more information on PrIMe molecular cancer test you can contact us here